Loading clinical trials...

COMPLETEDNANCT05362253

Micro-Conjunctival Autografting Combined With Amniotic Membrane Transplantation Treating Recurrent Pterygium Trial

To observe the effect of micro-conjunctival autografting combined with amniotic membrane transplantation on the postoperative recurrence, complications and ocular surface symptoms among patients with ...

Lead sponsor: Yifeng Yu•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Related studies

COMPLETED

Digital Colorimetric Scale for Recurrent Pterygium Scar Assessment

NCT07458126 · Recurrent Pterygium, Conjunctival Scarring

COMPLETEDNA

Evaluation of Conjunctival Autografting With MMC Application Versus Ologen Implantation of Recurrent Pterygium

NCT04419038 · Recurrent Pterygium of Eye

COMPLETEDPhase 4

Topical 0.2% Loteprednol Etabonate vs. Topical 0.1% Dexamethasone in Impending Recurrent Pterygium

NCT04075227 · Recurrent Pterygium of Eye, Steroid-Induced Glaucoma

UNKNOWNPhase 2

Ziv-aflibercept in Ocular Disease Requiring Anti-VEGF Injection

NCT02486484 · Neovascularization, Macular Degeneration, and more

COMPLETED

Clinical Analysis of Recurrence Patterns Following Conjunctival Autografts for Pterygium Surgery

NCT02059837 · Recurrent Pterygium

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: May 5, 2022Terms

Trial snapshot

StatusCOMPLETED

PhaseNA

Enrollment40

Start dateMar 2021

Last updatedMay 5, 2022

Condition

Recurrent Pterygium

Locations shown

the Second Affiliated Hospital of Nanchang University

Nanchang, Jiangxi

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: May 5, 2022Data synced to Clareo: May 3, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions